dual mobility cup: The use of a Sunfit dual mobility cup
unipolar cup: The use of a TMT cup
Study summary
The general purpose of this study is to examine whether the dual mobility cup (Novae® Serf) reduces the number of hip dislocations after total hip replacement, both early dislocation (≤1 year) and late dislocation (\>1 year) after primary THR compared with a conventional cup design (Trabecular MetalTM Modular Acetabular System).
Eligibility
Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Patients with hip arthritis who are amenable to surgery with THR and age ≥ 65 years referred to the Department of Orthopedic Surgery at either Section Farsø, Frederikshavn Hospital or Aalborg University Hospital. Patients who are willing to participate in the trial and who give their written, informed consent after receiving oral and written information.
Exclusion Criteria:
* Patients who do not wish to participate.
* Sequelae of Calvé-Legg-Perthes' disease, caput necrosis, epiphysiolysis.
* Proximal femoral or acetabular fracture.
* Hip dysplasia with subluxation Crowe types III and IV.
* Earlier hip bone surgery (excluding arthroscopic surgery).
* Elective bilateral surgery.
* If the patient's bone morphology is unsuitable for a cemented Exeter® femoral stem.
* Patients with no e-mail.
Primary outcome measure(s)
Early dislocation, Difference in dislocation within 1 year. — 1 year after surgery The primary outcome is the difference in cumulative incidence proportion of dislocation between the 2 randomized groups within the first year after total hip replacement. The information will be collected from both the patient through questionnaires and from the Danish Hip Arthroplasty Register and the Danish National Patient Register.
Trial sites (1)
Facility
City
Region
Status
Aalborg University Hospital
Aalborg
Northen Denmark
More Northern Orthopaedic Division, Denmark trials in Denmark
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.